[1]
|
Statistics and Outlook for Stomach Cancer. Cancer Research UK. Retrieved on 19 February 2014.
|
[2]
|
(2014) SEER Cancer Statistics FactSheets. http://seer.cancer.gov/statfacts/html/all.html
|
[3]
|
Kang, J.M., Lee, B.H., Kim, N., et al. (2011) CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer. Journal of Korean Medical Science, 26, 647-653. http://dx.doi.org/10.3346/jkms.2011.26.5.647
|
[4]
|
Barros, R., da Costa, L.T., Pinto-de-Sousa, J., et al. (2011) CDX2 Auto-Regulation in Human Intestinal Metaplasia of the Stomach: Impact on the Stability of the Phenotype. Gut, 60, 290-298. http://dx.doi.org/10.1136/gut.2010.222323
|
[5]
|
What Are the Risk Factors for Stomach Cancer (Website). American Cancer Society. Retrieved on 2010-03-31.
|
[6]
|
Ruddon, R.W. (2007) Cancer Biology. 4th Edition, Oxford University Press, Oxford, 223.
|
[7]
|
Orditura, M., Galizia, G., Sforza, V., Gambardella, V., Fabozzi, A., Laterza, M.M., Andreozzi, F., Ventriglia, J., Savastano, B., Mabilia, A., Lieto, E., Ciardiello, F. and De Vita, F. (2014) Treatment of Gastric Cancer. World Journal of Gastroenterology, 20, 1635-1649. http://dx.doi.org/10.3748/wjg.v20.i7.1635
|
[8]
|
Saucedo, L.J. and Edgar, B.A. (2007) Filling out the Hippo-Signaling Pathway. Nature Reviews Molecular Cell Biology, 8, 613-621. http://dx.doi.org/10.1038/nrm2221
|
[9]
|
Huang, M., Shen, A., Ding, J. and Geng, M. (2014) Molecularly Targeted Cancer Therapy: Some Lessons from the Past Decade. Trends in Pharmacological Sciences, 35, 41-50. http://dx.doi.org/10.1016/j.tips.2013.11.004
|
[10]
|
Hariharan, I.K. (2006) Growth Regulation: A Beginning for the Hippo-Signaling Pathway. Current Biology, 16, R1037-R1039. http://dx.doi.org/10.1016/j.cub.2006.11.012
|
[11]
|
Lai, Z.C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.L. and Li, Y. (2005) Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats. Cell, 120, 675-685. http://dx.doi.org/10.1016/j.cell.2004.12.036
|
[12]
|
Basu, S., Totty, N.F., Irwin, M.S., Sudol, M. and Downward, J. (2003) Akt Phosphorylates the Yes-Associated Protein, YAP, to Induce Interaction with 14-3-3 and Attenuation of p73-Mediated Apoptosis. Molecular Cell, 11, 11-23. http://dx.doi.org/10.1016/S1097-2765(02)00776-1
|
[13]
|
Vassilev, A., Kaneko, K.J., Shu, H., Zhao, Y. and De Pamphilis, M.L. (2001) TEAD/TEF Transcription Factors Utilize the Activation Domain of YAP65, a Src/Yes Associated Protein Localized in the Cytoplasm. Genes & Development, 15, 1229-1241. http://dx.doi.org/10.1101/gad.888601
|
[14]
|
Thompson, B.J. and Cohen, S.M. (2006) The Hippo-Signaling Pathway Regulates the Bantam microRNA to Control Cell Proliferation and Apoptosis in Drosophila. Cell, 126, 767-774. http://dx.doi.org/10.1016/j.cell.2006.07.013
|
[15]
|
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W.M. and Pan, D. (2010) Kibra Functions as a Tumor Suppressor Protein That Regulates Hippo Signaling in Conjunction with Merlin and Expanded. Developmental Cell, 18, 288-299. http://dx.doi.org/10.1016/j.devcel.2009.12.012
|
[16]
|
Yu, F.X. and Guan, K.L. (2013) The Hippo-Signaling Pathway: Regulators and Regulations. Genes & Development, 27, 355-371. http://dx.doi.org/10.1101/gad.210773.112
|
[17]
|
Yu, F.X., Zhao, B., Panupinthu, N., Jewell, J.L., Lian, I., Wang, L.H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X.D., Mills, G.B. and Guan, K.L. (2012) Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling. Cell, 150, 780-791. http://dx.doi.org/10.1016/j.cell.2012.06.037
|
[18]
|
Irvine, K.D. (2012) Integration of Intercellular Signaling through the Hippo-Signaling Pathway. Seminars in Cell & Developmental Biology, 23, 812-817. http://dx.doi.org/10.1016/j.semcdb.2012.04.006
|
[19]
|
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J.R., Zhou, D., et al. (2011) Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation. Cell, 144, 782-795. http://dx.doi.org/10.1016/j.cell.2011.02.031
|
[20]
|
Silvis, M.R., Kreger, B.T., Lien, W.-H., Klezovitch, O., Rudakova, G.M., Camargo, F.D., et al. (2011) α-Catenin Is a Tumor Suppressor That Controls Cell Accumulation by Regulating the Localization and Activity of the Transcriptional Coactivator Yap1. Science Signaling, 4, ra33. http://dx.doi.org/10.1126/scisignal.2001823
|
[21]
|
Cai, J., Zhang, N., Zheng, Y., de Wilde, R.F., Maitra, A. and Pan, D. (2010) The Hippo Signaling Pathway Restricts the Oncogenic Potential of an Intestinal Regeneration Program. Genes & Development, 24, 2383-2388. http://dx.doi.org/10.1101/gad.1978810
|
[22]
|
Enger, T.B., Samad-Zadeh, A., Bouchie, M.P., Skarstein, K., Galtung, H.K., Mera, T., Walker, J., Menko, A.S., Varelas, X., Faustman, D.L., Jensen, J.L. and Kukuruzinska, M.A. (2013) The Hippo Signaling Pathway Is Required for Salivary Gland Development and Its Dysregulation Is Associated with Sjogren’s Syndrome. Laboratory Investigation, 93, 1203-1218. http://dx.doi.org/10.1038/labinvest.2013.114
|
[23]
|
Bertini, E., Oka, T., Sudol, M., Strano, S. and Blandino, G. (2009) YAP: At the Crossroad between Transformation and Tumor Suppression. Cell Cycle, 8, 49-57. http://dx.doi.org/10.4161/cc.8.1.7259
|
[24]
|
Strano, S., Munarriz, E., Rossi, M., Castagnoli, L., Shaul, Y., Sacchi, A., Oren, M., Sudol, M., Cesareni, G. and Blandino, G. (2001) Physical Interaction with Yes-Associated Protein Enhances p73 Transcriptional Activity. The Journal of Biological Chemistry, 276, 15164-15173.
|
[25]
|
Wang, H., Du, Y.C., Zhou, X.J., Liu, H. and Tang, S.C. (2014) The Dual Functions of YAP-1 to Promote and Inhibit Cell Growth in Human Malignancy. Cancer and Metastasis Reviews, 33, 173-181. http://dx.doi.org/10.1007/s10555-013-9463-3
|
[26]
|
Hochhauser, J. and Tobias, D. (2010) Cancer and Its Management. 6th Edition, Wiley-Blackwell, Chichester, 259.
|
[27]
|
Nomura, A., Grove, J.S., Stemmermann, G.N. and Severson, R.K. (1990) Cigarette Smoking and Stomach Cancer. Cancer Research, 50, 7084.
|
[28]
|
Basu, S., Totty, N.F., Irwin, M.S., Sudol, M. and Downward, J. (2003) Akt Phosphorylates the Yes-Associated Protein, YAP, to Induce Interaction with 14-3-3 and Attenuation of p73-Mediated Apoptosis. Molecular Cell, 11, 11-23. http://dx.doi.org/10.1016/S1097-2765(02)00776-1
|
[29]
|
Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E. and Stocker, H. (2010) The WW Domain Protein Kibra Acts Upstream of Hippo in Drosophila. Developmental Cell, 18, 309-316. http://dx.doi.org/10.1016/j.devcel.2009.12.013
|
[30]
|
Bazellieres, E., Assemat, E., Arsanto, J.P., Le Bivic, A. and Massey-Harroche, D. (2009) Crumbs Proteins in Epithelial Morphogenesis. Frontiers in Bioscience, 14, 2149-2169. http://dx.doi.org/10.2741/3368
|
[31]
|
Wei, X., Shimizu, T. and Lai, Z.C. (2007) Mob as Tumor Suppressor Is Activated by Hippo Kinase for Growth Inhibition in Drosophila. The EMBO Journal, 26, 1772-1781. http://dx.doi.org/10.1038/sj.emboj.7601630
|
[32]
|
Lee, M.J., Ran Byun, M., Furutani-Seiki, M., Hong, J.H. and Jung, H.S. (2014) YAP and TAZ Regulate Skin Wound Healing. Journal of Investigative Dermatology, 134, 518-525. http://dx.doi.org/10.1038/jid.2013.339
|